国产三级理论电影,国模精品一区二区三区,操逼一区二区,人人操人人摸超碰,日韩深夜视频,亚洲中午字幕,黄拍一区,2018天天夜夜

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>

產(chǎn)品基本信息

產(chǎn)品編號：D230352

產(chǎn)品名稱：5-Dehydro Tolvaptan-d7

產(chǎn)品CAS：1296212-29-7

規(guī)格含量：25mg

產(chǎn)品價格：面議

聯(lián)系我們:

產(chǎn)品詳細介紹

標準品編號:	D230352
名稱:	5-Dehydro Tolvaptan-d7
別名:	N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide-d7; 1H-1-Benzazepine, Benzamide Deriv.-d7; 7-Chloro-1-[2-methyl-4-[(2-methylbenzoyl)amino]benzoyl]-5-Oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-d7
CAS號:	1296212-29-7
參考CAS號:	137973-76-3
分子式:	C??H??D?ClN?O?
外觀:	Off-white Solid
分子量:	453.97
種類:	Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
應用:	5-Dehydro Tolvaptan-d7 is an intermediate in synthesizing Tolvaptan-d7 (T536652), a labelled Tolvaptan. It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).
參考文獻	Paterna, S., et al.: Eur. J. Heart Fail, 2, 305 (2000); Udelson, J., et al.: Circulation, 104, 2417 (2001); Goldsmith, S., et al.: J. Am. Coll Cardiol., 46, 1785 (2005); Schrier, R., et al.: N. Engl. J. Med., 355, 2099 (2006)

聯(lián)系我們

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>